Articles published by MediWound Ltd.



MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023
April 26, 2023
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD

MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update
March 16, 2023
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD





MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares
February 07, 2023
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD

MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market
February 03, 2023
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD



MediWound Strengthens European Presence of NexoBrid®
December 20, 2022
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD

MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
December 19, 2022
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD

MediWound Expands Global Presence as NexoBrid® Gains Approval in India
December 13, 2022
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD

MediWound Announces a 1-for-7 Reverse Share Split
December 05, 2022
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD

MediWound to Report Third Quarter 2022 Financial Results
November 03, 2022
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD

MediWound Announces Formation of Strategic Advisory Board
October 25, 2022
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD


MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings
October 07, 2022
From MediWound Ltd.
Via GlobeNewswire
Tickers
MDWD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.